<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H6532DD8D3E474E65B86B13F60063E8F4" public-private="public" bill-type="olc"> 
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 HR 2421 IH: 21st Century Cures Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2015-05-19</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code> 
<congress>114th CONGRESS</congress>
<session>1st Session</session>
<legis-num>H. R. 2421</legis-num> 
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber> 
<action> 
<action-date date="20150519">May 19, 2015</action-date> 
<action-desc><sponsor name-id="B000213">Mr. Barton</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc>
</action> 
<legis-type>A BILL</legis-type> 
<official-title>To amend the Public Health Service Act to increase accountability at the National Institutes of Health.</official-title> 
</form> 
<legis-body id="HB52A970522E6460EA715901E3D33E964" style="OLC"> 
<section id="H982B36F6DBA0433E9FA7531A15F5238F" section-type="section-one"><enum>1.</enum><header>Increasing accountability at the National Institutes of Health</header> 
<subsection id="H7AA2E51D14044E4397F519F9EA8A9B47"><enum>(a)</enum><header>Appointment and terms of directors of national research institutes and national centers</header><text display-inline="yes-display-inline">Subsection (a) of section 405 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/284">42 U.S.C. 284</external-xref>) is amended to read as follows:</text> <quoted-block style="OLC" id="H73D0DD2DF1B2458192D22CEC5A373565" display-inline="no-display-inline"> <subsection id="HB1510C8AE4074208BF9AC3BF1651E000"><enum>(a)</enum><header>Appointment; terms</header> <paragraph id="HC4EC2FC6ADEB47FE9BBDD02A9559665D"><enum>(1)</enum><header>Appointment</header><text display-inline="yes-display-inline">The Director of the National Cancer Institute shall be appointed by the President and the directors of the other national research institutes, as well as the directors of the national centers, shall be appointed by the Director of NIH. The directors of the national research institutes, as well as national centers, shall report directly to the Director of NIH.</text></paragraph> 
<paragraph id="H71317AA28329417D9E028D5F9420832B"><enum>(2)</enum><header>Terms</header> 
<subparagraph id="H523DECE9C74842C1A6F253E8CDE049BD"><enum>(A)</enum><header>In general</header><text>The term of office of a director of a national research institute or national center shall be 5 years.</text></subparagraph> <subparagraph id="H227C29A679A84C7F8703A7C7E2722DC7"><enum>(B)</enum><header>Removal</header><text>The director of a national research institute or national center may be removed from office by the Director of NIH prior to the expiration of such director’s 5-year term.</text></subparagraph> 
<subparagraph id="H6D8A2555343D469EB8C303E23A555BEE"><enum>(C)</enum><header>Reappointment</header><text>At the end of the term of a director of a national research institute or national center, the director may be reappointed. There is no limit on the number of terms a director may serve.</text></subparagraph> <subparagraph id="H4CDCFD2B54B64760BA7F69B338EC1EBA"><enum>(D)</enum><header>Vacancies</header><text>If the office of a director of a national research institute or national center becomes vacant before the end of such director’s term, the director appointed to fill the vacancy shall be appointed for a 5-year term starting on the date of such appointment.</text></subparagraph> 
<subparagraph id="H82907D0054CB4CCBA910531813F544A4"><enum>(E)</enum><header>Transitional provision</header><text>Each director of a national research institute or national center serving on the date of enactment of the <short-title>21st Century Cures Act</short-title> is deemed to be appointed for a 5-year term under this subsection starting on such date of enactment.</text></subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection> <subsection id="H2CE08AC9CD74408D8BCBE62DE93C757A" commented="no"><enum>(b)</enum><header>Compensation to consultants or individual scientists</header><text>Section 202 of the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 1993 (<external-xref legal-doc="public-law" parsable-cite="pl/102/394">Public Law 102–394</external-xref>; <external-xref legal-doc="usc" parsable-cite="usc/42/238f">42 U.S.C. 238f</external-xref> note) is amended by striking <quote>portable structures;</quote> and all that follows and inserting <quote>portable structures.</quote>.</text></subsection> 
<subsection id="H0ECE0626DB69454588AD15849A7082F2"><enum>(c)</enum><header>Review of certain awards by directors</header><text display-inline="yes-display-inline">Section 405(b) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/284">42 U.S.C. 284(b)</external-xref>) is amended by adding at the end the following:</text> <quoted-block style="OLC" id="HC7A6E079254749FFB6CED43B080A59F2" display-inline="no-display-inline"> <paragraph id="HFDE5857B525E4A229988033F87CC681A" indent="up1"><enum>(3)</enum><text display-inline="yes-display-inline">Before an award is made by a national research institute or by a national center for a grant for a research program or project (commonly referred to as an <quote>R-series grant</quote>), other than an award constituting a noncompeting renewal of such grant, or a noncompeting administrative supplement to such grant, the director of such national research institute or national center—</text> 
<subparagraph id="H8376AF6D62B24E5E9861FC260E99C0E4"><enum>(A)</enum><text>shall review and approve the award; and</text></subparagraph> <subparagraph id="H64B4844A2FB146269B88DCB4499651E9"><enum>(B)</enum><text>shall take into consideration—</text> 
<clause id="HE252F4D16DC34DD8B10DC47C2640627F" commented="no"><enum>(i)</enum><text display-inline="yes-display-inline">the mission of the national research institute or national center and the scientific priorities identified in the strategic plan under section 402(m); and</text></clause> <clause id="HAE80DD1454164B628E6559382B1E74C3"><enum>(ii)</enum><text>whether other agencies are funding programs or projects to accomplish the same goal.</text></clause></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection> 
<subsection id="H7A51F2D6B1714C7AB162BD406CD5D8EE"><enum>(d)</enum><header>IOM study on duplication in Federal biomedical research</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services shall enter into an arrangement with the Institute of Medicine of the National Academies (or, if the Institute declines, another appropriate entity) under which the Institute (or other appropriate entity) not later than 2 years after the date of enactment of this Act will—</text> <paragraph id="HFF7597A237794540B2A5789BBD91E721"><enum>(1)</enum><text>complete a study on the extent to which biomedical research conducted or supported by Federal agencies is duplicative; and</text></paragraph> 
<paragraph id="H6388DDD122664DC8A6734C16F99292F8"><enum>(2)</enum><text>submit a report to the Congress on the results of such study, including recommendations on how to prevent such duplication.</text></paragraph></subsection></section> </legis-body> </bill> 

